Korean College of Helicobacter and Upper Gastrointestinal Research Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2008
NCT00926809
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2009

Timeline

NOW
  • Now

Alternative names

Korean Society of Helicobacter and Upper Gastrointestinal Research

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Dyspepsia (Phase 4)

Stomach Ulcer (Phase 4)

Ulcer (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 3